This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013:8:201-2.

doi: 10.2147/IJN.S41525. Epub 2013 Jan 9.

Personalized nanomedicine: future medicine for cancer treatment

Farooq A Shiekh

PMID: 23326194
PMCID: PMC3544349
DOI: 10.2147/IJN.S41525

Editorial

Personalized nanomedicine: future medicine for cancer treatment

Farooq A Shiekh. Int J Nanomedicine. 2013.

. 2013:8:201-2.

doi: 10.2147/IJN.S41525. Epub 2013 Jan 9.

Author

Farooq A Shiekh

PMID: 23326194
PMCID: PMC3544349
DOI: 10.2147/IJN.S41525

No abstract available

PubMed Disclaimer

Similar articles

Targeted Nanotechnology from Bench to Bedside.
Sapalidis K, Kosmidis C, Laskou S, Katsaounis A, Mantalobas S, Passos I, Michalopoulos N, Amaniti A, Sardeli C, Zarogoulidis P. Sapalidis K, et al. Curr Cancer Drug Targets. 2019;19(1):3-4. doi: 10.2174/156800961901181204130142. Curr Cancer Drug Targets. 2019. PMID: 30672409
Precision gas therapy using intelligent nanomedicine.
He Q. He Q. Biomater Sci. 2017 Oct 24;5(11):2226-2230. doi: 10.1039/c7bm00699c. Biomater Sci. 2017. PMID: 28937694 Review.
Realizing Cancer Precision Medicine by Integrating Systems Biology and Nanomaterial Engineering.
Joo JI, Choi M, Jang SH, Choi S, Park SM, Shin D, Cho KH. Joo JI, et al. Adv Mater. 2020 Sep;32(35):e1906783. doi: 10.1002/adma.201906783. Epub 2020 Apr 6. Adv Mater. 2020. PMID: 32253807 Review.
Unmet needs in developing nanoparticles for precision medicine.
Schwartz S Jr. Schwartz S Jr. Nanomedicine (Lond). 2017 Feb;12(4):271-274. doi: 10.2217/nnm-2016-0390. Epub 2017 Jan 17. Nanomedicine (Lond). 2017. PMID: 28093937 No abstract available.
Electron microscopy in human diseases: diagnostic and research perspectives.
Scimeca M, Montanaro M, Bonfiglio R, Anemona L, Bonanno E. Scimeca M, et al. Nanomedicine (Lond). 2019 Feb;14(4):371-373. doi: 10.2217/nnm-2018-0407. Epub 2019 Jan 18. Nanomedicine (Lond). 2019. PMID: 30767724 No abstract available.

See all similar articles

Cited by

Size dependent anti-invasiveness of silver nanoparticles in lung cancer cells.
Que YM, Fan XQ, Lin XJ, Jiang XL, Hu PP, Tong XY, Tan QY. Que YM, et al. RSC Adv. 2019 Jul 5;9(37):21134-21138. doi: 10.1039/c9ra03662h. eCollection 2019 Jul 5. RSC Adv. 2019. PMID: 35521328 Free PMC article.
Targeted nanotherapeutics in cancer.
Shiekh FA. Shiekh FA. Int J Nanomedicine. 2014 Mar 26;9:1627-8. doi: 10.2147/IJN.S62468. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24741302 Free PMC article. No abstract available.
Automatic Echographic Detection of Halloysite Clay Nanotubes in a Low Concentration Range.
Conversano F, Pisani P, Casciaro E, Di Paola M, Leporatti S, Franchini R, Quarta A, Gigli G, Casciaro S. Conversano F, et al. Nanomaterials (Basel). 2016 Apr 11;6(4):66. doi: 10.3390/nano6040066. Nanomaterials (Basel). 2016. PMID: 28335194 Free PMC article.
Trastuzumab-Targeted Biodegradable Nanoparticles for Enhanced Delivery of Dasatinib in HER2+ Metastasic Breast Cancer.
Niza E, Noblejas-López MDM, Bravo I, Nieto-Jiménez C, Castro-Osma JA, Canales-Vázquez J, Lara-Sanchez A, Galán Moya EM, Burgos M, Ocaña A, Alonso-Moreno C. Niza E, et al. Nanomaterials (Basel). 2019 Dec 16;9(12):1793. doi: 10.3390/nano9121793. Nanomaterials (Basel). 2019. PMID: 31888247 Free PMC article.
Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma.
Zielinska E, Zauszkiewicz-Pawlak A, Wojcik M, Inkielewicz-Stepniak I. Zielinska E, et al. Oncotarget. 2017 Nov 20;9(4):4675-4697. doi: 10.18632/oncotarget.22563. eCollection 2018 Jan 12. Oncotarget. 2017. PMID: 29435134 Free PMC article.

See all "Cited by" articles

References

1. Parkin DM. International variation. Oncogene. 2004;23:6329–6340. - PubMed
1. Sugahara KN, Teesalu T, Karmali PP, et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science. 2010;328:1031–1035. - PMC - PubMed
1. Colditz GA, Sellers TA, Trapido E. Epidemiology – identifying the causes and preventability of cancer? Nat Rev Cancer. 2006;6:75–83. - PubMed
1. Shiekh FA. Blood-brain barrier: a real obstacle for therapeutics. Int J Nanomedicine. 2012;7:4065–4066. - PMC - PubMed
1. Horton JK, Wilson SH. Predicting enhanced cell killing through PARP inhibition. Mol Cancer Res. 2012 Nov 27; [Epub ahead of print.] - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations